Frequently asked questions

Our program may include both FDA-approved medications and compounded formulations, depending on availability and your individual clinical factors. Compounded medications have not been evaluated by the FDA for safety, effectiveness, or quality. All medications are prescribed by a licensed provider and dispensed by a state-licensed pharmacy.

Both are prescription medications used to support weight management. Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP receptors. The right option depends on your health profile and goals, and your provider determines what is appropriate for you based on your assessment.

Injection bypasses gut absorption and delivers the full dose — helpful when appetite or absorption is reduced.

If you were low, energy often improves within days to a couple of weeks.

B12 is water-soluble; excess is largely excreted, so toxicity is very rare.

Many patients report reduced pain in 1–2 weeks; structural healing takes 4–8 weeks.

Subcutaneously, ideally near the injury — your provider will guide the site.

No — used off-label in performance and recovery medicine. Dispensed via our compounding pharmacy under provider supervision.

Getting started is simple. Sign up on our website for an initial consultation. The medical team will assess your health and weight management goals to develop an appropriate treatment plan based on your health assessment, which may include GLP-1 receptor agonists or dual GLP-1/GIP receptor agonist medications when appropriate.

You must be at least 18 years old and complete a health assessment. Eligibility is determined by a licensed provider based on your medical history, current medications, and weight management goals. Not everyone is a candidate; the provider's clinical review is what determines whether treatment is appropriate.

No. The process is fully online: you complete a health questionnaire, a licensed provider reviews it, and if treatment is appropriate, issues a prescription. No in-person visit is required.

Like all medications, GLP-1 receptor agonist medications can have side effects. Common side effects may include nausea, vomiting, diarrhea, and constipation. The medical team will monitor your progress and adjust your treatment as needed to help manage side effects and support your health journey. Individual responses to medications vary, and not all patients experience the same side effects or benefits.

GLP-1 medications are not appropriate for everyone. They are generally not recommended if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), a history of pancreatitis, or if you are pregnant, trying to become pregnant, or breastfeeding. Your intake questionnaire screens for these and other factors, and your provider makes the final determination.

Your provider determines your starting dose and any adjustments based on your health assessment and how you respond. Doses are typically increased gradually (titrated) to help manage side effects. Always take your medication exactly as prescribed, never adjust the dose on your own, and reach out to the care team with any concerns.

Both work. Subcutaneous gives systemic effect; topical works locally on skin.

Skin changes typically visible by week 6–12.

Generally well-tolerated. Watch for injection-site irritation; rare hypersensitivity.

The medical team determine appropriate medication options based on your health profile, weight management goals, and other medications you may be taking. This helps ensure that you receive an appropriate dosage based on clinical guidelines and your health assessment.

Your prescription will be sent directly to your preferred pharmacy or delivered to your home. Refills can be easily managed through our online portal or by contacting our support team. All medications are dispensed through licensed pharmacies in compliance with applicable regulations.

Medications are dispensed by a state-licensed pharmacy and shipped to the address you provide. When a medication needs to stay cold, it is packaged to protect it in transit, and you will receive tracking information when your order ships.

A provider-tailored stack — typically GHK-Cu and BPC-157 with optional add-ons. Your blend is on the label.

It's systemic, so it complements rather than competes with topicals.

Most patients run 8–12 weeks, then 4 weeks off.

Oral glutathione is poorly absorbed. Injection delivers active compound directly to circulation.

Many patients notice tone evening / brightening. Not a bleaching agent — it inhibits melanin synthesis.

Generally well tolerated; rare injection-site reactions. Sulfa allergies should be flagged.

Pricing is shown clearly before you check out, so what you see is what you pay, with no hidden fees. See each treatment's page for current pricing.

Compounded GLP-1 medications generally are not covered by insurance. Many patients pay with an HSA or FSA card using their prescription; keep your receipt for your records.

Phone support is available 7 days a week from 6am to 6pm Pacific time at 888-896-1612. Our healthcare team is available to address any questions about your treatment plan, potential side effects, or other concerns you may have.

No — it amplifies adaptations. Pair with a training stimulus.

Most patients notice improved energy in 2–4 weeks; metabolic markers shift over 8–12 weeks.

Generally well-tolerated. Watch for injection-site reactions.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell that plays a central role in energy production and metabolism. Supplementation is used to support cellular energy and overall wellness.

Experiences vary. Some people report support with energy, focus, and recovery. NAD+ is intended to complement, not replace, a healthy lifestyle and works best as part of a broader wellness approach.

NAD+ is administered by injection per your provider's instructions. Receiving it too quickly can cause temporary flushing, nausea, or chest tightness, so follow the recommended pace and dosing. Discuss any health conditions with your provider first.

Sildenafil acts on blood flow. PT-141 acts on central desire. Different problem, different mechanism.

Most common: nausea (~40% in trials), flushing, transient blood-pressure rise. Slow titration helps.

Max 2–3 times a week, never two doses within 24 hours.

It activates three receptors instead of one or two. Trial data suggests greater weight loss but also a steeper titration.

Not yet — it's in late-stage clinical trials. Compounded formulations are dispensed under physician supervision through our 503A pharmacy partner.

Retatrutide is an investigational molecule with no FDA-approved product, and compounded formulations have not been evaluated by the FDA. There is no established expectation for individual results; your provider will discuss what is and isn't known from ongoing research.

Semaglutide is a GLP-1 receptor agonist used to support weight management. It mimics the GLP-1 hormone to help regulate appetite and increase feelings of fullness. Compounded medications have not been evaluated by the FDA for safety, effectiveness, or quality.

By acting on GLP-1 receptors, semaglutide can reduce hunger and support weight management when combined with diet and exercise. Your provider starts you at a low dose and adjusts it gradually to help manage side effects.

The most common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, or constipation, and they often ease over time. Your care team will help you manage them, and individual responses vary.

Weight-loss results vary from person to person and depend on your dose, adherence, diet, and activity. Your provider tracks your progress at regular check-ins and adjusts your plan; most protocols are formally evaluated at 12 weeks. Individual results vary.

Take it within 5 days of the missed dose. If more, skip and take the next on schedule.

No. Compounded semaglutide is not Ozempic® or Wegovy®, and it is not a generic version of them. It contains the same active ingredient (semaglutide), but compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Your provider prescribes a compounded formulation only when it is clinically appropriate for you.

No — sermorelin asks your pituitary to make its own GH. Different mechanism, much milder side-effect profile.

Sleep usually improves in 1–2 weeks; body composition changes over 8–12 weeks.

Most common: transient injection-site irritation, vivid dreams. Rare: water retention, joint stiffness.

They slow gastric emptying and gut motility, which can harden and slow stool.

Stool softeners typically take 1–3 days — they're for comfort and prevention, not urgent relief.

Water, fiber, and movement. Tell your provider if constipation is severe or persistent.

TB-500 is more systemic; BPC-157 is more localized. Many protocols stack them.

Most patients report reduced pain and stiffness within 2–4 weeks; structural healing takes longer.

Generally well-tolerated. Watch for injection-site reactions or transient lethargy.

Tirzepatide is a dual GLP-1 and GIP receptor agonist used to support weight management by helping regulate appetite and metabolism. Compounded medications have not been evaluated by the FDA for safety, effectiveness, or quality.

By acting on both GLP-1 and GIP receptors, tirzepatide can reduce appetite and support weight management alongside diet and exercise. Your provider titrates the dose gradually based on how you respond.

The most common side effects are gastrointestinal, such as nausea, diarrhea, vomiting, or constipation, which often lessen as your body adjusts. Your care team monitors your progress and helps manage them.

Tirzepatide acts on two receptors (GLP-1 and GIP), while semaglutide acts on GLP-1 alone. Clinical trials of the FDA-approved products studied each medication separately — those trials did not study compounded formulations, and individual results vary. Your provider will discuss which option is appropriate for you.

No. Compounded tirzepatide is not Mounjaro® or Zepbound®, and it is not a generic version of them. It contains the same active ingredient (tirzepatide), but compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Your provider prescribes a compounded formulation only when it is clinically appropriate for you.

Most common: nausea, fullness, occasional GI upset. Slow titration manages it.

Typically BPC-157, TB-500, and GHK-Cu. Your provider tailors the ratio. Exact composition is on the label.

Most patients report reduced pain and improved sleep in 1–2 weeks; structural healing takes 4–8 weeks.

8–12 weeks on, 4 weeks off.